Detalhe da pesquisa
1.
Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control study.
J Antimicrob Chemother
; 79(1): 46-54, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37944018
2.
Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortality.
Med Mycol
; 61(4)2023 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37019819
3.
Toxigenic cutaneous diphtheria without recent travel, Sydney, Australia, 2022.
Med J Aust
; 220(3): 126-128, 2024 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111182
4.
An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric ß-lactam therapy.
Eur J Clin Microbiol Infect Dis
; 37(11): 2171-2175, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30120647
5.
Cluster of invasive Mycobacteria chimaera infections following cardiac surgery demonstrating novel clinical features and risks of aortic valve replacement.
Intern Med J
; 48(12): 1514-1520, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30517986
6.
Too much of a good thing: a retrospective study of ß-lactam concentration-toxicity relationships.
J Antimicrob Chemother
; 72(10): 2891-2897, 2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29091190
7.
Changing epidemiology of candidaemia in Australia.
J Antimicrob Chemother
; 72(4): 1103-1108, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28364558
8.
Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.
Immunity
; 28(6): 822-32, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18549801
9.
Correction to: An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric ß-lactam therapy.
Eur J Clin Microbiol Infect Dis
; 40(8): 1789, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34138416
10.
Economic evaluation of micafungin vs. liposomal amphotericin B (LAmB) for the treatment of candidaemia and invasive candidiasis (IC).
Mycoses
; 56(5): 532-42, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23496163
11.
Invasive Scedosporium and Lomentospora prolificans Infections in Australia: A Multicenter Retrospective Cohort Study.
Open Forum Infect Dis
; 10(2): ofad059, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861090
12.
Changing epidemiology of candidaemia in Australia.
J Antimicrob Chemother
; 72(4): 1270, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28204502
13.
Therapeutic drug monitoring practices of anti-infectives: An Asia-wide cross-sectional survey.
Front Pharmacol
; 13: 992354, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36299881
14.
Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis.
J Antimicrob Chemother
; 66(8): 1906-15, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21628305
15.
Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections.
Clin Pharmacokinet
; 60(6): 711-725, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33751415
16.
Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease.
Eur J Immunol
; 39(2): 391-403, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19180462
17.
Therapeutic drug monitoring of commonly used anti-infective agents: A nationwide cross-sectional survey of Australian hospital practices.
Int J Antimicrob Agents
; 56(6): 106180, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32987102
18.
Managing two decades of visceral leishmaniasis and HIV co-infection: a case report that illustrates the urgent research needs in the field.
Sex Health
; 14(3): 286-288, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28063460
19.
Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment-experienced, HIV-infected individuals: recent data and consensus recommendations.
HIV Clin Trials
; 7(2): 86-96, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16798623
20.
Skeletal muscle toxicity associated with raltegravir-based combination antiretroviral therapy in HIV-infected adults.
J Acquir Immune Defic Syndr
; 62(5): 525-33, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23274936